Medtech startup which has developed a device that allows patients to monitor themselves for potentially life-threatening side effects of chemotherapy
52 North Health has raised €2.6M across 2 funding rounds from 7 investors, most recently a Grant round in Nov 2022. Based in Cambridge, UK; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-11-23 | Grant | €1.4M | Innovate UK | View deal → |
| 2022-04-28 | Other | €1.2M | Angel Investors,Cambridge Enterprise,Crista Galli Ventures,King’s Health Partners MedTech Innovations,Meltwind,Milltrust Ventures | View deal → |
